The approval for commercialisation of genetically modified maize now lies with the Cabinet after scientists concluded the field trials and handed the report to the Kenya Plant Health Inspectorate Service (Kephis) for registration.
The acting chief executive officer of the National Biosafety Authority (NBA), Roy Mugiira said a Cabinet memo was prepared early this year by principal secretaries in the line ministries and it is now awaiting approval.
